Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D Leverson, Darren C Phillips, Michael J Mitten, Erwin R Boghaert, Dolores Diaz, Stephen K Tahir, Lisa D Belmont, Paul Nimmer, Yu Xiao, Xiaoju Max Ma, Kym N Lowes, Peter Kovar, Jun Chen, Sha Jin, Morey Smith, John Xue, Haichao Zhang, Anatol Oleksijew, Terrance J Magoc, Kedar S Vaidya Show all
Science Translational Medicine | AMER ASSOC ADVANCEMENT SCIENCE | Published : 2015
Awarded by Independent Research Institutes Infrastructure Support Scheme
Awarded by Direct For Computer & Info Scie & Enginr
Awarded by Division of Computing and Communication Foundations
Work in the Huang Lab is supported by grants and fellowships from the Australian National Health and Medical Research Council (research fellowships to D.C.S.H.; project grants to D.C.S.H.; program grants 461219, 461221, and 1016701; and Independent Research Institutes Infrastructure Support Scheme grant 361646), the Cancer Council Victoria (grant-in-aid to D.C.S.H.), the Leukemia and Lymphoma Society (Specialized Centers of Research grants), the Australian Cancer Research Foundation, and a Victorian State Government Operational Infrastructure Support grant.